A survey of the currently known mast cell mediators with potential relevance for therapy of mast cell-induced symptoms

por Molderings, Gerhard J., Afrin, Lawrence B.
Publicado 2023

Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome

por Afrin, Lawrence B., Weinstock, Leonard B., Molderings, Gerhard J.
Publicado 2020

Efficacy and toxicity of hydroxyurea in mast cell activation syndrome patients refractory to standard medical therapy: retrospective case series

por Weinstock, Leonard B., Brook, Jill B., Molderings, Gerhard J.
Publicado 2022

Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options

por Molderings, Gerhard J, Brettner, Stefan, Homann, Jürgen, Afrin, Lawrence B
Publicado 2011

Case Report: Treatment of systemic mastocytosis with sunitinib

por Molderings, Gerhard J., Afrin, Lawrence B., Hertfelder, Hans-Jörg, Brettner, Stefan
Publicado 2017

Familial Occurrence of Systemic Mast Cell Activation Disease

por Molderings, Gerhard J., Haenisch, Britta, Bogdanow, Manuela, Fimmers, Rolf, Nöthen, Markus M.
Publicado 2013

Risk of solid cancer in patients with mast cell activation syndrome: Results from Germany and USA

por Molderings, Gerhard J., Zienkiewicz, Thomas, Homann, Jürgen, Menzen, Markus, Afrin, Lawrence B.
Publicado 2017

Health-related quality of life and health literacy in patients with systemic mastocytosis and mast cell activation syndrome

por Schmidt, Tobias Jürgen, Sellin, Julia, Molderings, Gerhard J., Conrad, Rupert, Mücke, Martin
Publicado 2022

Correction : Health-related quality of life and health literacy in patients with systemic mastocytosis and mast cell activation syndrome

por Schmidt, Tobias Jürgen, Sellin, Julia, Molderings, Gerhard J., Conrad, Rupert, Mücke, Martin
Publicado 2023

Cluster-Analytic Identification of Clinically Meaningful Subtypes in MCAS: The Relevance of Heat and Cold

por Häder, Tinus, Molderings, Gerhard J., Klawonn, Frank, Conrad, Rupert, Mücke, Martin, Sellin, Julia
Publicado 2023

Prostaglandin D(2)-supplemented “functional eicosanoid testing and typing” assay with peripheral blood leukocytes as a new tool in the diagnosis of systemic mast cell activation di...

por Schäfer, Dirk, Dreßen, Peter, Brettner, Stefan, Rath, Norbert-Folke, Molderings, Gerhard J, Jensen, Katrin, Ziemann, Christina
Publicado 2014

Determination of Plasma Heparin Level Improves Identification of Systemic Mast Cell Activation Disease

por Vysniauskaite, Milda, Hertfelder, Hans-Jörg, Oldenburg, Johannes, Dreßen, Peter, Brettner, Stefan, Homann, Jürgen, Molderings, Gerhard J.
Publicado 2015

Effects of Primary Mast Cell Disease on Hemostasis and Erythropoiesis

por Seidel, Holger, Hertfelder, Hans-Jörg, Oldenburg, Johannes, Kruppenbacher, Johannes P., Afrin, Lawrence B., Molderings, Gerhard J.
Publicado 2021

Mast cell activation symptoms are prevalent in Long-COVID

por Weinstock, Leonard B., Brook, Jill B., Walters, Arthur S., Goris, Ashleigh, Afrin, Lawrence B., Molderings, Gerhard J.
Publicado 2021

The 1,4-benzodiazepine Ro5-4864 (4-chlorodiazepam) suppresses multiple pro-inflammatory mast cell effector functions

por Yousefi, Omid Sascha, Wilhelm, Thomas, Maschke-Neuß, Karin, Kuhny, Marcel, Martin, Christian, Molderings, Gerhard J, Kratz, Felix, Hildenbrand, Bernd, Huber, Michael
Publicado 2013

Pharmacological treatment options for mast cell activation disease

por Molderings, Gerhard J., Haenisch, Britta, Brettner, Stefan, Homann, Jürgen, Menzen, Markus, Dumoulin, Franz Ludwig, Panse, Jens, Butterfield, Joseph, Afrin, Lawrence B.
Publicado 2016